A systematic comparison of clinically viable nanomedicines targeting HMG-CoA reductase in inflammatory atherosclerosis.
Journal of Controlled Release.
Times cited: 10
Immune cell screening of a nanoparticle library improves atherosclerosis therapy.
Proceedings of the National Academy of Sciences of the United States of America.
Times cited: 28